Prior endoscopy in patients with newly diagnosed celiac disease: A missed opportunity?

Digestive Diseases and Sciences

Volumn 58, Issue 5, 2013, Pages 1293-1298

  Lebwohl, Benjamin ^a,b   Bhagat, Govind ^a   Markoff, Sarah ^a   Lewis, Suzanne K ^a   Smukalla, Scott ^a   Neugut, Alfred I ^b   Green, Peter H R ^a  

^a Department of Medicine   (United States)

^b Department of Medicine   (United States)

Author keywords

Biopsy; Celiac disease; Diagnosis; Endoscopy

Indexed keywords

ADULT; ARTICLE; CELIAC DISEASE; CROSS-SECTIONAL STUDY; DUODENOSCOPY; DUODENUM BIOPSY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL;

CELIAC DISEASE; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84878706655     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2551-3     Document Type: Article

References (24)

1. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88-93.
2. Murray JA, Van Dyke C, Plevak MF, Dierkhising RA, Zinsmeister AR, Melton LJ III. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol. 2003;1:19-27.
3. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011;106:1333-1339.
4. Catassi C, Kryszak D, Bhatti B, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530-538.
5. Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538-1544.
6. Catassi C, Kryszak D, Louis-Jacques O, et al. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol. 2007;102:1454-1460.
7. Arguelles-Grande C, Tennyson CA, Lewis SK, Green PH, Bhagat G. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol. 2012;65:242-247.
8. Lebwohl B, Tennyson CA, Holub JL, Lieberman DA, Neugut AI, Green PH. Sex and racial disparities in duodenal biopsy to evaluate for celiac disease. Gastrointest Endosc. 2012;76:779-785.
9. Lebwohl B, Kapel RC, Neugut AI, Green PH, Genta RM. Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc. 2011;74:103-109.
10. Catassi C, Fabiani E, Ratsch IM, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl. 1996;412:29-35.
11. Virta LJ, Kaukinen K, Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol. 2009;44:933-938.
12. Fisher ES, Welch HG. Could more health care lead to worse health? Hosp Pract (Minneap) 1999;34:15-16, 21-22.
13. Lieberman D, Fennerty MB, Morris CD, Holub J, Eisen G, Sonnenberg A. Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology. 2004;127:1067-1075.
14. Green PH, Murray JA. Routine duodenal biopsies to exclude celiac disease? Gastrointest Endosc. 2003;58:92-95.
15. Ford AC, Ching E, Moayyedi P. Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia. Aliment Pharmacol Ther. 2009;30:28-36.
16. Collin P, Mustalahti K, Kyronpalo S, Rasmussen M, Pehkonen E, Kaukinen K. Should we screen reflux oesophagitis patients for coeliac disease? Eur J Gastroenterol Hepatol. 2004;16:917-920.
17. Nachman F, Vazquez H, Gonzalez A, et al. Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet. Clin Gastroenterol Hepatol. 2011;9:214-219.
18. Leffler DA, Kelly CP. Celiac disease and gastroesophageal reflux disease: yet another presentation for a clinical chameleon. Clin Gastroenterol Hepatol. 2011;9:192-193.
19. Hershcovici T, Leshno M, Goldin E, Shamir R, Israeli E. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther. 2010;31:901-910.
20. Dickey W, Hughes D. Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol. 2001;96:2126-2128.
21. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520-2524.
22. Harewood GC, Holub JL, Lieberman DA. Variation in small bowel biopsy performance among diverse endoscopy settings: results from a national endoscopic database. Am J Gastroenterol. 2004;99:1790-1794.
23. Abrams JA, Diamond B, Rotterdam H, Green PH. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci. 2004;49:546-550.
24. Giangreco E, D'Agate C, Barbera C, et al. Prevalence of celiac disease in adult patients with refractory functional dyspepsia: value of routine duodenal biopsy. World J Gastroenterol. 2008;14:6948-6953.